tiprankstipranks
Trending News
More News >
Fulgent Genetics (FLGT)
NASDAQ:FLGT
US Market

Fulgent Genetics (FLGT) Financial Statements

Compare
1,642 Followers

Fulgent Genetics Financial Overview

Fulgent Genetics's market cap is currently $430.67M. The company's EPS TTM is $0.16; its P/E ratio is ―; Fulgent Genetics is scheduled to report earnings on February 27, 2026, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 322.67M$ 283.47M$ 289.21M$ 618.97M$ 992.58M
Gross Profit$ 130.88M$ 107.22M$ 104.46M$ 366.90M$ 777.05M
Operating Income$ -91.10M$ -73.92M$ -195.53M$ 178.53M$ 675.95M
EBITDA$ -45.83M$ -48.99M$ -147.45M$ 217.70M$ 686.96M
Net Income$ -60.51M$ -42.71M$ -167.82M$ 143.40M$ 507.36M
Balance Sheet
Cash & Short-Term Investments$ 336.08M$ 258.11M$ 424.15M$ 526.24M$ 450.50M
Total Assets$ 1.21B$ 1.22B$ 1.24B$ 1.39B$ 1.28B
Total Debt$ 476.00K$ 8.47M$ 15.25M$ 38.94M$ 21.28M
Net Debt$ -49.72M$ -46.68M$ -82.22M$ -40.57M$ -143.61M
Total Liabilities$ 106.81M$ 90.81M$ 102.04M$ 116.18M$ 112.84M
Stockholders' Equity$ 1.11B$ 1.13B$ 1.14B$ 1.27B$ 1.16B
Cash Flow
Free Cash Flow$ -124.21M$ -19.25M$ 4.80M$ 234.75M$ 514.73M
Operating Cash Flow$ -101.64M$ 21.06M$ 27.00M$ 253.52M$ 538.58M
Investing Cash Flow$ 111.37M$ -58.35M$ 38.90M$ -261.31M$ -546.55M
Financing Cash Flow$ -14.79M$ -4.85M$ -47.78M$ -77.14M$ 85.41M
Currency in USD

Fulgent Genetics Earnings and Revenue History

Fulgent Genetics Debt to Assets

Fulgent Genetics Cash Flow

Fulgent Genetics Forecast EPS vs Actual EPS